138 related articles for article (PubMed ID: 2855411)
41. Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography.
Chung JK; Jang JJ; Lee DS; Lee MC; Koh CS
J Nucl Med; 1994 Sep; 35(9):1499-505. PubMed ID: 8071700
[TBL] [Abstract][Full Text] [Related]
42. [Phagocytic activity in various lung tumors].
Mikhova Ts; Uzunov P; Vlasov V; Vodenicharova S
Eksp Med Morfol; 1988; 27(3):39-43. PubMed ID: 2851435
[No Abstract] [Full Text] [Related]
43. [Tumor-associated markers in malignant lung neoplasms].
Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
[TBL] [Abstract][Full Text] [Related]
44. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
[No Abstract] [Full Text] [Related]
45. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
46. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
47. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
[TBL] [Abstract][Full Text] [Related]
48. [Immunopathological factors influencing the prognosis after resection of lung cancer].
Zhang YF
Zhonghua Wai Ke Za Zhi; 1990 Jul; 28(7):424-6, 446-7. PubMed ID: 2269051
[TBL] [Abstract][Full Text] [Related]
49. BCM-IMx behaviour in patients with lung diseases.
Allende MT; Hernández J; Fernández Fernández M; Fernández Llana B; Suarez B; Ruibal A
Bull Cancer; 1991; 78(9):843-5. PubMed ID: 1661198
[No Abstract] [Full Text] [Related]
50. Bronchoalveolar lavage fluid level of carcinoembryonic antigen in the diagnosis of peripheral lung cancer.
Sanguinetti CM; Riccioni G; Marchesani F; Pela R; Cecarini L
Monaldi Arch Chest Dis; 1995 May; 50(3):177-82. PubMed ID: 7663486
[TBL] [Abstract][Full Text] [Related]
51. [Immuno-oncologic monitoring of patients with bronchial carcinoma. I. Carcinoembryonic antigen (CEA)].
Mancuso M; Leonardo E; Sanfilippo B; Dogliotti C; Oliaro A; Maggi G
Minerva Med; 1985 Jan; 76(1-2):15-9. PubMed ID: 3974915
[TBL] [Abstract][Full Text] [Related]
52. A correlative study of bronchial cytology, bronchoalveolar lavage (BAL) and serum tumor markers in the diagnosis of lung carcinoma.
Nikliński J; Chyczewski L; Chyczewska E; Laudański J; Furman M
Folia Histochem Cytobiol; 1993; 31(4):211-3. PubMed ID: 8138002
[TBL] [Abstract][Full Text] [Related]
53. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
54. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
55. [Tumor marker in lung cancer].
Shijubo N; Abe S
Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
[No Abstract] [Full Text] [Related]
56. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
57. [Value of monitoring serum carcinoembryonic antigen (CEA) levels for prognosis of patients with lung cancer treated by non-surgical methods].
Ochnio J; Rogińska E; Kwiek S; Rowińska-Zakrzewska E
Pneumonol Pol; 1984 Jul; 52(7):321-9. PubMed ID: 6093066
[No Abstract] [Full Text] [Related]
58. [Clinical evaluation of serum CEA levels in cases of unresectable lung cancer].
Satoh T; Yananuma Y; Moriya H; Hoshino T; Kimura K; Fujita T; Higuchi Y; Togawa T
Rinsho Hoshasen; 1986 Nov; 31(12):1409-13. PubMed ID: 3029465
[No Abstract] [Full Text] [Related]
59. [Immunological status in small cell and squamous cell lung cancer].
Janicka G; Przylipiak M; Chyczewska E; Kowal E
Pol Tyg Lek; 1983 Aug; 38(32):985-8. PubMed ID: 6320142
[No Abstract] [Full Text] [Related]
60. [The distribution of HLA-system antigens in lung cancer patients].
Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
